Vanda Pharmaceuticals (VNDA) Competitor Comparison
We are evaluating the key criteria listed to compare Vanda Pharmaceuticals (VNDA) against its competitors in the Biotechnology industry.
Market Capitalization
210 / 368Gross Profits
28 / 278Total Revenue
58 / 300EBITDA
32 / 337Free Cashflow
25 / 352Quick Ratio
151 / 357Earnings per Share
56 / 359Dividend yield
0 / 6Total Cash
63 / 358Performance 3 years
207 / 368Performance 5 years
203 / 368Performance 10 years
163 / 368Linearity 3 years
167 / 368Linearity 5 years
146 / 368Linearity 10 years
63 / 368Total Rank
27 / 368Dividend Rank
19 / 368Valuation Rank
112 / 368Piotroski Rank
117 / 368Muliplier Rank
107 / 368Total Cash - VNDA ranking 63 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.